Specialised Therapeutics Australia
Drug Stores & Pharmacies · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
L 2 17 Cotham Rd, Kew, Victoria, 3101, A...Phone Number
+65 31589940Website
www.stabiopharma.comRevenue
$8.8 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Specialised Therapeutics Australia
Specialised Therapeutics collaborates with global partners to introduce new specialist medicines to patients in Australia, New Zealand, and Southeast Asia. The company focuses on addressing unmet medical needs by commercializing therapies and technologies with high professional and ethical standards. They have established partnerships with 18 international companies and have contributed significantly to research, development, and philanthropic efforts. Their mission includes improving access to treatments for rare diseases and supporting patients through compassionate drug donations.Explore more
Specialised Therapeutics Australia Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Specialised Therapeutics Australia your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Specialised Therapeutics Australia recently announced quarterly report
Click to see if Specialised Therapeutics Australia had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Specialised Therapeutics Australia
Check if Specialised Therapeutics Australia has recently received funding, and reach out quickly before it becomes old news!
Check out if Specialised Therapeutics Australia is spiking on competitors!
Product Launch: Get notified when Specialised Therapeutics Australia launches new products
Funding: Get notified immidiatlly once Specialised Therapeutics Australia has new funding data
Specialised Therapeutics Australia, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Specialised Therapeutics Australia as Masked Content
Find more new buyers
Compare Similar Companies to Specialised Therapeutics Australia
Compare insights from companies similar to Specialised Therapeutics Australia, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Specialised Therapeutics Australia is experiencing very low activity levels compared to other companies in the Retail sector.
What does this means?
Specialised Therapeutics Australia is drawing exceptional interest within the Retail industry, suggesting notable developments or strong market momentum, learn more about Specialised Therapeutics Australia.
Specialised Therapeutics Australia Tech Stack
A closer look at the technologies used by Specialised Therapeutics Australia
See more technologies
Specialised Therapeutics Australia News & Media
FIRST AND ONLY TREATMENT FOR CHRONIC HYPOPARATHYROIDISM APPROVED IN AUSTRALIA
YORVIPATH® (palopegteriparatide) is now registered by the Therapeutic Goods Administration (TGA) for the treatment of chronic hypoparathyroidism in adults1 First-in-class novel PTH replacement therapy Australia becomes the first country to obtain Marketing Authorisation for YORVIPATH...New Breast Cancer Therapy to Reduce Risk of Recurrence and Improve Disease-Free Survival Now Approved in Thailand
NERLYNX® (neratinib) has been approved as a single agent for the treatment of early-stage HER2+ breast cancer, and in combination with capecitabine for the treatment of advanced or metastatic HER2+ breast cancer[1] Approval coincides with the first appointment of field force employees,...Specialised Therapeutics signs exclusive license agreement with CanariaBio for new ovarian cancer therapy
.. First ovarian cancer therapy for ST oncology portfolio .. Phase 2 study demonstrated oregovomab in combination with chemotherapy improved progression free survival by ~30 months compared to chemotherapy alone 1 .. Phase 3 results expected in 2025 .. Exclusive license for AU, NZ, Singapore, Malaysia, Brunei, Thailand and Vietnam SINGAPORE and SEOUL, South Korea, Oct. 13, 2023 /PRNewswire/ -- Independent biopharmaceutical company Specialised Therapeutics Asia Pte Ltd (ST) has signed a license dWorld Orphan Drug Alliance Welcomes Specialised Therapeutics
SEA's largest independent specialty pharma company Specialised Therapeutics (ST) has joined global pharma consortium committed to collaborating to provide new specialist medicines for rare diseases. ST to represent WODA in Australia, New Zealand and across Southeast Asia (ANZSEA). World...
Read more news
Top Drug Stores & Pharmacies Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Specialised Therapeutics Australia
Sign Up For FreeTo access detailed company insights
Specialised Therapeutics collaborates with global partners to introduce new specialist medicines to patients in Australia, New Zealand, and Southeast Asia. The company focuses on addressing unmet medical needs by commercializing therapies and technologies with high professional and ethical standards. They have established partnerships with 18 inter... Read More
